Sigma-Aldrich — Shareholder Meeting (May 2011)
25 slides from Sigma-Aldrich's shareholder meeting presentation, May 6, 2011
Slide 1: Sigma-Aldrich Corporation 2011 Shareholders Meeting
• May 3, 2011 Sigma-Aldrich Corporation 2011 Shareholders Meeting sigma-aldrich.com Exhibit 99.1
Slide 2: We have a bright future ahead
We have a bright future ahead 2010/2011 – Important Transition Years • 2010 and Q1 2011 performance was outstanding • Company is financially strong • Management transition
Slide 3: Delivering science with convenience
Delivering science with convenience Sigma-Aldrich – Unique Business Model • Leading Life Science and Hitech Company • Diversified and broad portfolio – Products – Customers • Expanding global footprint • Unrivalled customer service • World-class management team • Consistently strong financial perfor
Slide 4: Full Year 2010 Financial Results
Year-Over-Year Year-Over-Year Achieved new performance record in 2010 Full Year 2010 Financial Results $ Millions, Except Per Share Amounts As Reported Excluding Currency Impact Sales $2,271 6% 5% As Reported Excluding Restructuring and Impairment Costs As Reported Excluding Restructuring and Impair
Slide 5: Sales Mix: 2010 Sales Growth
Sales Mix (YTD) Demand for Research products continued to show growth. SAFC sales set new annual high 28% SAFC Full Year 2010 / Full Year 2009 2010 Sales Growth Adjusted for Currency 72% Research 5% Total Company 9% SAFC 4% Research
Slide 6: First Quarter 2011 Financial Results
Year-Over-Year Year-Over-Year Q1 Sales and Net Income highest in Company history First Quarter 2011 Financial Results $ Millions, Except Per Share Amounts Q1 2011 As Reported Excluding Currency and Acquisition Impacts Sales $632 10% 7% As Reported Q1 2011 Excluding Restructuring and Tax Benefit As R
Slide 7: Sales Mix: Q1 2011 Sales Growth
Sales Mix (YTD) Demand for Research products met expectations. SAFC sales set new quarterly high 28% SAFC Q1 2011 / Q1 2010 2011 Sales Growth 72% Research 10% 18% 8% Reported Organic* 7% Total Company 16% SAFC 4% Research *Adjusted for Currency and Acquisitions.
Slide 8: Key Balance Sheet Metrics
3/31/11 12/31/09 12/31/10 Strong financial position Key Balance Sheet Metrics 21.5% 18.8% 6.5 $ 623 6.5 6.3 Inventory MOH 25.5% 21.4% Debt to Capital 22.8% 21.5% Return on Equity $ 373 Receivable DSO Total Debt ($M) $ 569 Cash ($M)
Slide 9: Management Transition
Strong leadership team – Aligned with strategic plan initiatives Loss of Jai Nagarkatti Management Team Management Transition Rakesh Sachdev Kirk Richter Interim CFO Dave Smoller Chief Scientific Officer Eric Green Asia Pacific/Latin Amer. Mike Harris EMEA Gerrit van den Dool North America Regions G
Slide 10: Technology Initiatives
• Technology Initiatives Recent Company Highlights and Achievements • Won silver award in The Scientist magazine for top 10 innovations for 2010 for engineering cell lines and knock-out rats using Zinc Finger Nuclease (ZFN) technology • Expanded offering of Antibodies • Expanded manufacturing of lar
Slide 11: Customer Service
• Customer Service Recent Company Highlights and Achievements • New warehouse management system with Virtual Boxing at the Milwaukee Distribution Center • Sigma-Aldrich China received “Preferred Supplier Award” from GSK and Aleve China • Continued strong service levels in North America and Europe; i
Slide 12: Growth Accelerators
• Growth Accelerators Recent Company Highlights and Achievements • SAFC Biosciences – Biological drugs • SAFC Hitech – Chemicals for LEDs and semiconductors • Emerging Markets – Strong growth in China, India & Brazil: 25% in Q1 2011 (31% in 2010) • eCommerce – Increased to 50% of global Research sal
Slide 13: Company / Employee
• Company / Employee Recent Company Highlights and Achievements Recognition • Recognized as Top 100 Employers in UK, France, Germany and Switzerland • Prestigious James B. Eads Award for outstanding achievement in Technology and Engineering in St. Louis awarded to Samy Ponnusamy for his work in Poly
Slide 14: Corporate Citizenship
• Corporate Citizenship Recent Company Highlights and Achievements • Team Sigma-Aldrich increased volunteer participation and contributions • Launched Global Citizenship Initiative • Sigma-Aldrich and Sigma-Aldrich Foundation donated ~$1 million • Japan earthquake relief fund of $100K
Slide 15: Enhance Growth in Core Research and SAFC Business
• Enhance Growth in Core Research Sigma-Aldrich Strategic Priorities and SAFC Business • Focus on higher growth markets – Analytical Chemistry – Biology – Chemistry/Materials Science • Capitalize on SAFC’s unique manufacturing capabilities and cGMP facilities • Increased presence in faster-growth ec
Slide 16: Drive Operational Excellence, Leverage Strong Cash Flow
• Drive Operational Excellence • Leverage Strong Cash Flow Strategic actions build sustainable value Sigma-Aldrich Strategic Priorities • Continue to build upon the success of our global supply chain initiatives • Streamline manufacturing and distribution footprint • Expand global sourcing • Activel
Slide 17: 2011 Guidance
Organic Revenue Growth Diluted Adjusted EPS* Free Cash Flow 2011 Guidance *Excludes any restructuring and other extraordinary special charges. Mid-single digits $3.60 – $3.75 >$400 Million
Slide 18: Five-Year Financial Targets 2011-2015
Deliver above-market top-line growth and profits Incremental Impact Five-Year Financial Targets Objectives: 2011–2015 >$2 Billion Cumulative free cash flow (five years) 26–27% Expand cumulative operating margins by 2015 7–8% Top line organic growth (normal economic conditions)
Slide 19: Shareholder Returns
SIAL Total Shareholder Return for 2010 exceeds 30% Shareholder Returns Peers: Life Technologies, Qiagen, Techne, Thermo-Fisher, Waters, Agilent, Becton Dickinson, Bio-Rad, PerkinElmer, Lonza $124.27 $176.39 $137.81 $222.56 $167.03 $100.00 $235.62 $0 $50 $100 $150 $200 $250 30-Apr SIAL PEERS Nasdaq 1
Slide 20: Sigma-Aldrich: A Bright Future
Compelling investment opportunity Sigma-Aldrich: A Bright Future Unrivaled scientific knowledge and unsurpassed service Diversified portfolio: products, customers Expanding global footprint History of profitable growth Strong financial position and cash flow Plans to enhance growth rates and improve
Slide 21: Questions?
Sigma-Aldrich Corporation 2011 Shareholders Meeting Questions?
Slide 22: Appendix
Appendix Reconciliation of GAAP to Non-GAAP Financial Measures
Slide 23: Reconciliation of Reported Sales Growth to Adjusted (Organic) Sales Growth
Reconciliation of Reported Sales Growth to Adjusted (Organic) Sales Growth 7% 1% 2% 10% Total Customer Sales 16% – 2% 18% SAFC 4% 2% 2% 8% Research Chemicals 4% – 2% 6% Research Biotech 4% 3% 2% 9% Research Specialties 5% – 2% 7% Research Essentials Adjusted (Organic) Acquisition Benefit Currency Be
Slide 24: Reconciliation of Reported Net Income to Adjusted Net Income
Reconciliation of Reported Net Income to Adjusted Net Income $2.85 $3.31 $0.84 $0.94 $353 $104 $116 Adjusted net income – – – (0.04) – – – (5) Tax benefit _ 0.05 – – – – – Impairment charge 0.05 0.14 0.03 0.01 Restructuring costs $2.80 $3.12 $0.81 $0.97 $347 $384 $100 $119 Reported net income Twelve
Slide 25: Reconciliation of Operating Cash Flow to Free Cash Flow
Reconciliation of Operating Cash Flow to Free Cash Flow $ Millions Free cash flow Less: Capital expenditures Net cash provided by operating activities $ 133 $ 133 (18) (18) $ 151 $ 151 Three Months Ended March 31, $ 396 $ 424 (120) (99) $ 516 $ 523 Twelve Months Ended December 31,